Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
4.780
+0.020 (0.42%)
At close: Jun 27, 2025, 4:00 PM
5.01
+0.23 (4.81%)
After-hours: Jun 27, 2025, 6:09 PM EDT
Avalo Therapeutics Market Cap
Avalo Therapeutics has a market cap or net worth of $51.76 million as of June 27, 2025. Its market cap has increased by 358.02% in one year.
Market Cap
51.76M
Enterprise Value
-72.81M
1-Year Change
358.02%
Ranking
Category
Stock Price
$4.78
Market Cap Chart
Since November 13, 2015, Avalo Therapeutics's market cap has increased from $34.50M to $51.76M, an increase of 50.02%. That is a compound annual growth rate of 4.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 51.50M | -33.29% |
| Dec 31, 2024 | 77.20M | 957.53% |
| Dec 29, 2023 | 7.30M | -84.60% |
| Dec 30, 2022 | 47.40M | -75.17% |
| Dec 31, 2021 | 190.90M | -3.49% |
| Dec 31, 2020 | 197.80M | -16.79% |
| Dec 31, 2019 | 237.70M | 80.35% |
| Dec 31, 2018 | 131.80M | 58.03% |
| Dec 29, 2017 | 83.40M | 917.07% |
| Dec 30, 2016 | 8.20M | -71.63% |
| Dec 31, 2015 | 28.90M | -16.23% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 714.27B |
| Johnson & Johnson | 367.23B |
| AbbVie | 329.43B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 275.26B |
| Abbott Laboratories | 232.09B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |